Matthew

Analyst

Stifel

Equibles does not estimate personal net worth.

About Matthew

Matthew is recorded as Analyst at Stifel. Matthew has spoken on 3 earnings calls across 3 companies, most recently for uniQure N.V. on November 4, 2026. Those appearances were for uniQure N.V. (QURE), Acumen Pharmaceuticals, Inc. (ABOS) and Rhythm Pharmaceuticals, Inc. (RYTM). The companies whose calls Matthew spoke on are classified in the Healthcare sector.

Matthew on recent calls

“I guess maybe a question for Kylie, you know, how quickly would you anticipate patients would be able to get therapy, assuming the positive outcome from the Mepidufa, and what would be the gating factor there?”

Analyst — Stifel, uniQure to Announce Third Quarter 2026 Financial Results · November 4, 2026

“In the selection of your EBD candidates, what were the parameters that you sought to optimize, and where do you think the second molecule might be better than the bispecific Sybarra Tug?”

Analyst — Stifel, Acumen Pharma Q2 2026 Conference Call and Webcast · August 12, 2026